Skip to main content

Table 2 Five-year survival estimates and 95% confidence intervals (CI) of patients with TNBC (TNBC) and without TNBC (non-TNBC) - overall survival, and survival by treatment received

From: The treatment and survival of patients with triple negative breast cancer in a London population

 

TNBC

Non-TNBC

 

5-year survival

(95% CI)

5-year survival

(95% CI)

Overall

0.62

(0.53, 0.69)

0.75

(0.72, 0.78)

Treatment received:

    

Surgery

0.65

(0.54, 0.74)

0.86

(0.84, 0.89)

Chemotherapy

0.65

(0.53, 0.74)

0.77

(0.71, 0.81)

Surgery plus chemotherapy

0.74

(0.60, 0.83)

0.86

(0.80, 0.90)

Radiotherapy

0.30

(0.12, 0.50)

0.87

(0.82, 0.91)